ALVO

ALVO

USD

Alvotech Ordinary Shares

$4.830-0.260 (-5.108%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Luxemburg

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$5.090

Hoch

$5.100

Tief

$4.700

Volumen

0.89M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.5B

Branche

Drug Manufacturers - Specialty & Generic

Land

Luxembourg

Handelsstatistiken

Durchschnittliches Volumen

0.47M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $4.7Aktuell $4.830Hoch $13.7

Ähnliche Nachrichten

GlobeNewswire

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO). The investigation concerns whether the

Mehr anzeigen
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
Analyst Upgrades

Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8

Deutsche Bank analyst Niall Alexander downgrades Alvotech from Buy to Hold and lowers the price target from $14 to $8.

Mehr anzeigen
Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8
GlobeNewswire

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today

Mehr anzeigen
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
GlobeNewswire

Alvotech Announces Changes in Global Business Development and Commercial Operations Team

REYKJAVIK, Iceland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced

Mehr anzeigen
Alvotech Announces Changes in Global Business Development and Commercial Operations Team

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.